Kidney Transplantation in an Elderly Veteran Population With Hepatitis C Virus Nucleic Acid Test–Positive Donors Results in Improved Outcomes After Prophylactic Glecaprevir/Pibrentasvir Therapy

•The use of hepatitis C virus nucleic acid test (HCV NAT)-positive kidneys continues to be an untapped resource to increase transplant rates.•To our knowledge, insufficient information exists on the use of glecaprevir/pibrentasvir following HCV NAT-positive transplants in elderly patients.•The use o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation proceedings 2023-03, Vol.55 (2), p.317-324
Hauptverfasser:	Lopez-Soler, Reynold I., Thorndyke, Anne, Trotter, Christine, Zingraf, Gerry, Sorenson, Jeffrey, Samra, Manpreet
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antiviral Agents - therapeutic use Hepacivirus - genetics Hepatitis C - diagnosis Hepatitis C - drug therapy Hepatitis C - prevention & control Hepatitis C, Chronic - drug therapy Humans Kidney Transplantation - adverse effects Prospective Studies Tissue Donors Veterans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!